Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
Venous thromboembolism (VTE) is a common complication in patients with cancer. Data on the role of natural inhibitors of coagulation for occurrence of cancer-associated VTE are limited, thus, we investigated the association of tissue factor pathway inhibitor (TFPI) with risk of VTE and all-cause mo...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2023-10-01
|
| Col·lecció: | Haematologica |
| Accés en línia: | https://haematologica.org/article/view/11300 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|